Please try another search
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Name | Age | Since | Title |
---|---|---|---|
Avner Hagai | 68 | 2006 | Founder & Director |
David Zacut | 71 | 2006 | Co-Founder & Vice-Chairman |
Abraham Zangen | 54 | 2006 | Co-Founder, Member of Scientific Advisory Board & Director |
Karen Sarid | 74 | 2017 | Independent Director |
Mark S. George | - | - | Member of the Scientific Advisory Board |
Mark Hallett | - | - | Member of the Scientific Advisory Board |
David Feifel | - | - | Member of the Scientific Advisory Board |
Markus Heilig | - | 2022 | Member of Scientific Advisory Board |
Zafiris Daskalakis | - | 2021 | Member of the Scientific Advisory Board |
Amiram Boehm | 53 | 2023 | Independent Chairman |
Yossi Ben Shalom | 68 | 2018 | Independent Director |
Avner Lushi | 58 | 2020 | Independent Director |
Eti Mitrany | 54 | 2016 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review